|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 118.40 PLN | -0.50% |
|
-1.33% | -13.07% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +66.55% | 1 | ||||
| 56.55 | -2.31% | 11 | ||||||
| 22.29 | -0.11% | 7 | ||||||
| 8.8 | +71.54% | 10 | ||||||
| - | - | 48.3 | +31.14% | 1 | ||||
| 35.4 | -5.88% | 5 | ||||||
| 5.9 | -16.31% | 5 | ||||||
| - | 44,500 | +61.52% | 2 | |||||
| 8.333 | +68.01% | 3 | ||||||
| Average | 4,987.08 | +30.46% | 5 | ||||||
| Weighted average by Cap. | 2,305.99 | +15.56% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
